Literature DB >> 12692268

Association of bovine papillomavirus with the equine sarcoid.

G Chambers1, V A Ellsmore2, P M O'Brien1, S W J Reid2, S Love2, M S Campo1, L Nasir2.   

Abstract

The equine sarcoid, a locally aggressive, fibroblastic skin tumour, is the most common dermatological neoplasm reported in horses; there is no consistently effective therapy. It is widely accepted that bovine papillomavirus (BPV) types 1 and 2 are associated with the pathogenesis of sarcoid disease. Most sarcoids appear to contain detectable viral DNA and RNA and are also known to express the BPV types 1 and 2 major transforming protein, E5, but appear not to produce infectious virions. While the mode of transmission of infection has not been elucidated, viral gene expression, in particular of E5, may contribute to virus persistence and disease pathogenesis by downregulating MHC class I expression. Here, the pathology and epidemiology of the sarcoid and its association with BPV is reviewed; the transforming functions of the BPV oncoproteins and their possible role in sarcoid pathogenesis are discussed; and the practical implications of BPV infection for diagnostic and therapeutic purposes are considered.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12692268     DOI: 10.1099/vir.0.18947-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  32 in total

1.  A novel murine model for evaluating bovine papillomavirus prophylactics/therapeutics for equine sarcoid-like tumours.

Authors:  Lies Bogaert; Andrew W Woodham; Diane M Da Silva; Ann Martens; Evelyne Meyer; W Martin Kast
Journal:  J Gen Virol       Date:  2015-06-04       Impact factor: 3.891

2.  Evaluation of equine papillomas, aural plaques, and sarcoids for the presence of Equine papillomavirus DNA and Papillomavirus antigen.

Authors:  Rosemary C Postey; Greg D Appleyard; Beverly A Kidney
Journal:  Can J Vet Res       Date:  2007-01       Impact factor: 1.310

3.  Squamous cell carcinoma and suspect peripheral nerve sheath tumor in a 10-year-old Paint horse.

Authors:  Natalie Reid
Journal:  Can Vet J       Date:  2009-11       Impact factor: 1.008

4.  Autologous vaccination for the treatment of equine sarcoids: 18 cases (2009-2014).

Authors:  Caitlin C Rothacker; Ashley G Boyle; David G Levine
Journal:  Can Vet J       Date:  2015-07       Impact factor: 1.008

5.  Safety and immunogenicity of BPV-1 L1 virus-like particles in a dose-escalation vaccination trial in horses.

Authors:  E K Hainisch; S Brandt; S Shafti-Keramat; R Van den Hoven; R Kirnbauer
Journal:  Equine Vet J       Date:  2011-09-06       Impact factor: 2.888

6.  Identification of a novel human gammapapillomavirus species.

Authors:  Linlin Li; Pennan Barry; Elaine Yeh; Carol Glaser; David Schnurr; Eric Delwart
Journal:  J Gen Virol       Date:  2009-07-01       Impact factor: 3.891

Review 7.  Recent advances in preclinical model systems for papillomaviruses.

Authors:  Neil D Christensen; Lynn R Budgeon; Nancy M Cladel; Jiafen Hu
Journal:  Virus Res       Date:  2016-12-09       Impact factor: 3.303

8.  Inoculation of young horses with bovine papillomavirus type 1 virions leads to early infection of PBMCs prior to pseudo-sarcoid formation.

Authors:  Bettina Hartl; Edmund K Hainisch; Saeed Shafti-Keramat; Reinhard Kirnbauer; Annunziata Corteggio; Giuseppe Borzacchiello; Reinhard Tober; Christina Kainzbauer; Barbara Pratscher; Sabine Brandt
Journal:  J Gen Virol       Date:  2011-06-29       Impact factor: 3.891

9.  Analysis of host-parasite incongruence in papillomavirus evolution using importance sampling.

Authors:  Seena D Shah; John Doorbar; Richard A Goldstein
Journal:  Mol Biol Evol       Date:  2010-01-21       Impact factor: 16.240

Review 10.  Mus musculus Papillomavirus 1: a New Frontier in Animal Models of Papillomavirus Pathogenesis.

Authors:  Megan E Spurgeon; Paul F Lambert
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.